China develops artificial heart with rocket technology: Report

Image
Press Trust of India Beijing
Last Updated : Mar 15 2018 | 11:30 AM IST

Chinese scientists have developed an artificial heart using rocket technology and it is currently undergoing testing after thorough experiments on animals, a media report said today.

The heart was developed jointly by the China Academy of Launch Vehicle Technology (CALT) and the Teda International Cardiovascular Hospital in North China's Tianjin.

The artificial heart has been sent for testing and inspection after thorough experiments on animals, Science and Technology Daily reported, citing Li Hong, former director of CALT from the state-owned China Aerospace Science and Technology Corporation.

The artificial heart uses magnetic and fluid levitation from a rocket system, and the "aerospace heart" is expected to move to clinical trials during the 13th Five-Year Plan (2016-20), state-run Global Times reported.

"The magnetic and fluid levitation technology can reduce the friction in the device to increase the working efficiency and extend the life span of the power generator," the report quoted as saying Song Zhongping, a military expert and TV commentator.

This technology used can reduce damage to the blood and enable the blood pump to work longer.

"There is no self-made artificial heart approved for sale in China. For now, patients have to rely on heart transplants," Sun Hongtao, associate chief physician at the Fuwai Cardiovascular Hospital, told Science and Technology Daily.

"An imported artificial heart could cost 100,000 euros (USD 152,800). If China could produce its own artificial heart at a lower cost, that will definitely benefit heart patients in China," Sun said.

Fuwai Cardiovascular Hospital also developed an artificial heart using magnetic levitation, and the man-made hearts have been planted in three of the patients from June to October 2017, state-run Xinhua News Agency reported on March 9.

Sun said artificial hearts were typically used while waiting for a heart transplant, or to permanently replace the heart in case heart transplants are not possible.

In 2013, scientists planted a man-made heart in a sheep, which survived for 120 days in good health.

The hearts were then placed in six other sheep and all survived 100 days or longer, which proved that the heart is qualified for batch production, the Science and Technology report said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 15 2018 | 11:30 AM IST

Next Story